Skip to content

The efficacy of Transcranial Vagus Nerve Stimulation for constipation associated with Parkinson's Disease

The efficacy of Transcranial Vagus Nerve Stimulation for constipation associated with Parkinson's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109749
Enrollment
Unknown
Registered
2025-09-24
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

constipation in Parkinson's disease

Interventions

Control group:vagus nerve stimulation
stimulated group:vagus nerve stimulation

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Diagnosed with PD18 according to the Clinical Diagnostic Criteria for Parkinson's Disease of the Movement Disorder Society, with H&Y staging =24 points.

Exclusion criteria

Exclusion criteria: 1.Use of probiotics or antibiotics within the past 4 weeks; 2.Severe intestinal disorders (such as intestinal obstruction, colitis, etc.) or a history of abdominal surgery Severe intestinal disorders (e.g., intestinal obstruction, colitis, etc.), history of abdominal surgery; 3.Recent use of medications that may affect intestinal function (such as antibiotics, strong painkillers, etc.); 4.Accompanied by severe neurological or psychiatric, renal, cardiovascular, cancer, or hepatic disease; 5.Pregnant women or breastfeeding women; 6.Allergies to electrodes, contraindications; 7.Serious medical conditions that may interfere with the study protocol or confound endpoint assessments: such as uncontrolled hypertension, concomitant diabetes, organ failure, current substance abuse, or inability to provide informed consent; 8.Any other circumstances deemed inappropriate for participation by the researcher; 9.Participation in other concurrent clinical trials.

Design outcomes

Primary

MeasureTime frame
Number of bowel movements;

Secondary

MeasureTime frame
UPDRS;amplitude in EEG;Quality of Life Related to Constipation;Severity of Constipation;Fecal consistency;

Countries

China

Contacts

Public ContactWu Yiwen

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

wyw11380@rjh.com.cn+86 13916235834

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026